Search

Your search keyword '"Tamsulosin"' showing total 6,003 results

Search Constraints

Start Over You searched for: Descriptor "Tamsulosin" Remove constraint Descriptor: "Tamsulosin"
6,003 results on '"Tamsulosin"'

Search Results

16. Evaluation of the Effect of an α-Adrenergic Blocker, a PPAR-γ Receptor Agonist, and a Glycemic Regulator on Chronic Kidney Disease in Diabetic Rats.

17. Tadalafil use is associated with a lower incidence of Type 2 diabetes in men with benign prostatic hyperplasia: A population‐based cohort study.

18. Clinical determination of the natural distensibility of the human ureter: initial study.

19. Efficacy of Low-Dose Deflazacort with Tamsulosin in the Medical Expulsive Therapy of Distal Ureterolithiasis: A Randomized Controlled Trial.

20. Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery.

21. Effect of Tamsulosin on Lower Urinary Tract Symptoms in Elderly Patients with Benign Prostatic Hyperplasia.

22. Exposure to Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease: A Meta-Analysis.

23. Preoperative α1-Blockers Impact on Outcomes of Patients Undergoing Ureteroscopy with Ureteral Access Sheaths: A Systematic Review and Meta-Analysis.

24. A randomized control study on post-operative iris distortion following small-pupil cataract surgery using B-HEX pupil expander versus Malyugin ring.

25. Alpha-adrenergic antagonists and iris dynamics: Challenges and solutions in cataract surgery

32. Comparing monotherapy with tadalafil or tamsulosin in men with benign prostatic hyperplasia: A case–control study

33. Effect of preoperative alpha‐blockers on ureteroscopy outcomes: A meta‐analysis of randomised trials

34. Effect of perioperative tamsulosin on successful ureteral access sheath placement and stent-related symptom relief: A double-blinded, randomized, placebo-controlled study

35. Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone

36. Relief of double-J stent-related symptoms: a comparison between mirabegron, tamsulosin and solifenacin

37. Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication.

38. Effect of different alpha-receptor antagonists on metabolic parameters: a head-to-head comparison.

39. Population pharmacokinetics of tamsulosine in patients with benign prostatic hyperplasia.

40. Comparative Approaches in Treating Double-J Stent Syndrome: Monotherapy or Combination Therapy?

41. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study.

42. Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone.

43. Relief of double-J stent-related symptoms: a comparison between mirabegron, tamsulosin and solifenacin.

44. Pooled-analysis of tadalafil and tamsulosin for ureteral calculi.

45. Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention.

46. The Role of Alpha Blocker Drugs in Reducing Double J Stent Related Symptoms.

47. Comparative study of tamsulosin, tadalafil, and combination of tamsulosin with tadalafil in the treatment of patients with lower urinary tract symptoms.

48. Assessing safety and tolerability of super selective alpha-1 adrenergic blockers in infants under 3 years: Insights from a single-center study on lower urinary tract obstruction (LUTO).

49. Evaluation of Tamsulosin 0.4 mg versus 0.8 mg in management of lower urinary tract symptoms due to benign prostatic enlargement.

50. Efficacy of Low-Dose Deflazacort with Tamsulosin in the Medical Expulsive Therapy of Distal Ureterolithiasis: A Randomized Controlled Trial

Catalog

Books, media, physical & digital resources